Susan Schumer

2.2k citations

17 papers · 1.2k indexed · h-index 9

Impact in

Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments

Papers in ⓘ

Oncology 9
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- Cancer survivorship and care 2
Pulmonary and Respiratory Medicine 5
- Lung Cancer Treatments and Mutations 3

Co-authors: Stephen A. Cannistra (2 shared papers)Daniel B. Costa (1 shared paper)Susumu Kobayashi (1 shared paper)Daniel G. Tenen (1 shared paper)Titus J. Boggon (1 shared paper)Mark S. Huberman (2 shared papers)Balázs Halmos (2 shared papers)Alexi A. Wright (8 shared papers)
Journals: Journal of Clinical Oncology (7 papers)Gynecologic Oncology (4 papers)Clinical Lung Cancer (1 paper)PLoS Medicine (1 paper)Breast Cancer Research and Treatment (1 paper)
Partner nations: United States Italy Denmark

In The Last Decade

Susan Schumer

16 papers receiving 1.2k citations

Peers

Countries citing papers authored by Susan Schumer

Since Specialization

Citations

This map shows the geographic impact of Susan Schumer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Schumer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Schumer more than expected).

Fields of papers citing papers by Susan Schumer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Schumer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Schumer. The network helps show where Susan Schumer may publish in the future.

Co-authors

The 25 scholars most cited alongside Susan Schumer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan Schumer Line = papers co-authored together Susan Schumer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Granulosa Cell Tumor of the Ovary Journal of Clinical Oncology ·Susan Schumer, Stephen A. Cannistra	2003	447
2	BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations PLoS Medicine ·Daniel B. Costa, Balázs Halmos, Amit Kumar, Susan Schumer, Mark S. Huberman, Titus J. Boggon, Daniel G. Tenen, Susumu Kobayashi	2007	408
3	Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma Journal of Clinical Oncology ·Joyce F. Liu, Niya Xiong, Susana M. Campos, Alexi A. Wright, Carolyn Krasner, Susan Schumer, Neil S. Horowitz, Jennifer Veneris, Nabihah Tayob, Stephanie Morrissey, Gabriela West, Roxanne Quinn, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos	2021	115
4	Urinary Metalloproteinases: Noninvasive Biomarkers for Breast Cancer Risk Assessment Cancer Epidemiology Biomarkers & Prevention ·Susan Pories, David Zurakowski, Roopali Roy, Carolyn C. Lamb, Sughra Raza, Alexis Exarhopoulos, Rochelle Scheib, Susan Schumer, Corrine Lenahan, Virginia F. Borges, Gwendolyn W. Louis, Ankur Anand, Nina V. Isakovich, J Hirshfield-Bartek, Ulla M. Wewer, Margaret Lotz, Marsha A. Moses	2008	77
5	Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer Breast Cancer Research and Treatment ·Erica L. Mayer, Ann H. Partridge, Lyndsay N. Harris, Rebecca Gelman, Susan Schumer, Harold J. Burstein, Eric P. Winer	2009	45
6	Efficacy of Pegfilgrastim and Darbepoetin Alfa As Hematopoietic Support for Dose-Dense Every-2-Week Adjuvant Breast Cancer Chemotherapy Journal of Clinical Oncology ·Harold J. Burstein, Leroy M. Parker, Aparna Keshaviah, Jennifer A. Doherty, Ann H. Partridge, Lidia Schapira, Paula D. Ryan, Jerry Younger, Lyndsay N. Harris, Beverly Moy, Steven E. Come, Susan Schumer, Craig A. Bunnell, Margaret Haldoupis, Rebecca Gelman, Eric P. Winer	2005	43
7	LBA35 Phase II study of PARP inhibitor talazoparib and PD-L1 inhibitor avelumab in patients (pts) with microsatellite stable (MSS) recurrent/persistent endometrial cancer Annals of Oncology ·P.A. Konstantinopoulos, A.A. Gockley, Niya Xiong, Nabihah Tayob, Carolyn Krasner, Mary K. Buss, Susana M. Campos, Susan Schumer, Alexi A. Wright, J.F. Liu, Meghan Shea, Yeku Oladapo, Cesar M. Castro, Madeline Polak, C. Whalen, Sara Bouberhan, S A Cannistra, Richard T. Penson, Gini F. Fleming, Ursula A. Matulonis	2020	11
8	Stepping into survivorship pilot study: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors Gynecologic Oncology ·Elizabeth Schrier, Niya Xiong, Embree Thompson, Hanneke Poort, Susan Schumer, Joyce F. Liu, Carolyn Krasner, Susana M. Campos, Neil S. Horowitz, Colleen M. Feltmate, Panagiotis A. Konstantinopoulos, Margaret Dinardo, Nabihah Tayob, Ursula A. Matulonis, Mitesh S. Patel, Alexi A. Wright	2021	9
9	A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma. Journal of Clinical Oncology ·Joyce F. Liu, Niya Xiong, Susana M. Campos, Alexi A. Wright, Carolyn Krasner, Susan Schumer, Neil S. Horowitz, Jennifer Veneris, Nabihah Tayob, Stephanie Morrissey, Gabriela West, Roxanne Quinn, Ursula A. Matulonis, Panagiotis A. Konstantinopoulos	2020	8
10	Phase 2, two-group, two-stage, open-label study of avelumab in patients with microsatellite stable, microsatellite instable and POLE-mutated recurrent or persistent endometrial cancer. Journal of Clinical Oncology ·Panagiotis A. Konstantinopoulos, Joyce F. Liu, William T. Barry, Carolyn Krasner, Mary K. Buss, Michael J. Birrer, Sarah Farooq, Susana M. Campos, Elizabeth H. Stover, Susan Schumer, Alexi A. Wright, Jennifer Curtis, Ariana Peralta, Christin Whalen, Don S. Dizon, Richard T. Penson, Stephen A. Cannistra, Gini F. Fleming, Ursula A. Matulonis	2017	6
11	Phase II, two-stage study of avelumab in patients with microsatellite stable (MSS), microsatellite instable (MSI) and polymerase epsilon (POLE) mutated recurrent or persistent endometrial cancer Gynecologic Oncology ·Panagiotis A. Konstantinopoulos, J.F. Liu, W Barry, Carolyn Krasner, Mary K. Buss, Michael J. Birrer, Sarah Farooq, Susana M. Campos, Ed Stover, Susan Schumer, Alexi A. Wright, Don S. Dizon, Wenjie Luo, R. T. Penson, S A Cannistra, Gini F. Fleming, Ursula A. Matulonis	2018	5
12	A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma Gynecologic Oncology ·J.F. Liu, Nabihah Tayob, Susana M. Campos, Alexi A. Wright, Carolyn Krasner, Susan Schumer, Neil S. Horowitz, J.L.T. Veneris, Niya Xiong, Gun West, Roxanne Quinn, Ursula A. Matulonis, P.A. Konstantinopoulos	2020	3
13	Phase II Trial of Sequential Chemotherapy Followed by Chemoradiation, Surgery, and Postoperative Chemotherapy for the Treatment of Stage IIIA/IIIB Non-Small-Cell Lung Cancer Clinical Lung Cancer ·Prudence Lam, Stuart M. Berman, Robert L. Thurer, Simon Ashiku, Malcolm M. DeCamp, Michael A. Goldstein, Susan Schumer, Balázs Halmos, Daniel D. Karp, Danielle Coute, Mark Bergman, Cynthia Boyd-Sirard, Sai‐Hong Ignatius Ou, Alona Muzikansky, C. Woodard, Mark S. Huberman	2006	2
14	Abstract PO1-09-10: County-level Social Vulnerability and Survival among Women with Inflammatory Breast Cancer Cancer Research ·Kelly A. Hirko, Elizabeth Troll, Sean Ryan, Faina Nakhlis, Jennifer R. Bellon, Olga Kantor, Christina Minami, Eren D. Yeh, Ilana Schlam, Laura Warren, Caroline Block, Susan Schumer, Filipa Lynce	2024	1
15	Stepping into survivorship: Harnessing mobile health and principles of behavioral economics to increase physical activity in ovarian cancer survivors Gynecologic Oncology ·Alexi A. Wright, Elizabeth Schrier, Embree Thompson, Susan Schumer, J.F. Liu, Carolyn Krasner, Susana M. Campos, N.S. Horowitz, P.A. Konstantinopoulos, Margaret Dinardo, J.L.T. Veneris, U. Matulonis, M. Patel	2020	1
16	Combination therapy with gefitinib and capecitabine in metastatic breast cancer (MBC): A phase I trial Journal of Clinical Oncology ·Erica L. Mayer, Lyndsay N. Harris, Ann H. Partridge, R. S. Gelman, Susan Schumer, R. S. Comanaru, Miaoyun Long, Ebonie Sampson, Harold J. Burstein, Eric P. Winer	2006	1
17	The TRADE study: A phase 2 trial to assess the tolerability of abemaciclib dose escalation in early-stage HR+/HER2- breast cancer. Journal of Clinical Oncology ·Erica L. Mayer, Dario Trapani, Se Eun Kim, Meredith Faggen, Natalie Sinclair, Pedro Sanz-Altamira, Chiara Battelli, Shana Berwick, K. M. Steve Lo, Jose Acevedo, Sarah J. Sinclair, AJ Malcolm, Leticia Varella, Sarah Sammons, Susan Schumer, Philip D. Poorvu, Erin R. Wallace, Esther Pasternak, Nabihah Tayob, Sara M. Tolaney	2025	0

About Susan Schumer

Susan Schumer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Renal and related cancers (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer-related gene regulation (2 papers) and Cancer survivorship and care (2 papers). The work is most often cited by research in Reproductive Medicine (425 citations), Obstetrics and Gynecology (177 citations), Family Practice (36 citations), Oncology (422 citations) and Pulmonary and Respiratory Medicine (338 citations). Susan Schumer has collaborated with scholars based in United States, Italy and Denmark. Frequent co-authors include Stephen A. Cannistra, Daniel B. Costa, Susumu Kobayashi, Daniel G. Tenen, Titus J. Boggon, Mark S. Huberman, Balázs Halmos, Alexi A. Wright, Ursula A. Matulonis and Carolyn Krasner. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Clinical Lung Cancer, PLoS Medicine and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact